Rafferty Asset Management, LLC Karyopharm Therapeutics Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$2.84 - $3.92 $615,243 - $849,209	216,635 Added 31.1%	913,301 $3.55 Million
Q4 2022 Feb 13, 2023	BUY	$2.48 - $5.93 $71,081 - $169,965	28,662 Added 4.29%	696,666 $2.37 Million
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $851,067 - $1.21 Million	208,595 Added 45.41%	668,004 $3.65 Million
Q2 2022 Aug 12, 2022	SELL	$4.15 - $8.37 $1.45 Million - $2.93 Million	-349,530 Reduced 43.21%	459,409 $2.07 Million
Q1 2022 May 13, 2022	BUY	$5.91 - $14.38 $2.53 Million - $6.16 Million	428,371 Added 112.56%	808,939 $5.96 Million
Q4 2021 Feb 10, 2022	BUY	$5.21 - $8.61 $49,937 - $82,526	9,585 Added 2.58%	380,568 $2.45 Million
Q3 2021 Nov 10, 2021	BUY	$4.45 - $10.63 $526,074 - $1.26 Million	118,219 Added 46.77%	370,983 $2.16 Million
Q2 2021 Aug 10, 2021	SELL	$8.11 - $11.11 $145,160 - $198,857	-17,899 Reduced 6.61%	252,764 $2.61 Million
Q1 2021 May 10, 2021	BUY	$9.85 - $17.69 $2.09 Million - $3.75 Million	211,730 Added 359.27%	270,663 $2.85 Million
Q4 2020 Feb 10, 2021	SELL	$14.15 - $17.19 $1.14 Million - $1.39 Million	-80,796 Reduced 57.82%	58,933 $912,000
Q3 2020 Nov 13, 2020	BUY	$14.14 - $19.71 $1.17 Million - $1.63 Million	82,552 Added 144.38%	139,729 $2.04 Million
Q2 2020 Aug 07, 2020	BUY	$16.6 - $25.25 $742,883 - $1.13 Million	44,752 Added 360.18%	57,177 $1.08 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $1.34 Million - $2.58 Million	-93,232 Reduced 88.24%	12,425 $239,000
Q4 2019 Feb 10, 2020	SELL	$9.23 - $19.67 $839,505 - $1.79 Million	-90,954 Reduced 46.26%	105,657 $2.03 Million
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $1.11 Million - $2.33 Million	196,611 New	196,611 $1.89 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account